Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mishima

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
JACC. Heart Failure|September 7, 2023
Identification of Subclinical Heart Failure With Preserved Ejection Fraction in Patients With Symptomatic Atrial FibrillationJonathan P Ariyaratnam, Adrian D Elliott, Ricardo S Mishima, et al.
JACC. Clinical Electrophysiology|February 8, 2023
An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled TrialAdrian D Elliott, Christian V Verdicchio, Rajiv Mahajan, et al.
Heart, Lung & Circulation|April 24, 2022
Should We Check It? Assessing Interrogation of Cardiac Implantable Electronic Devices in the Emergency Department-The CHECK-ED Study: Implications for Service Planning and Care DeliveryBradley M Pitman, Vincent Schirripa, Dian A Munawar, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Safety and efficacy of perioperative FLOT regimen in Japanese patients with gastric, esophagogastric junction, or esophageal adenocarcinoma: a single-institution experienceS Takei, A Kawazoe, A Jubashi, et al.
Heart Rhythm|December 21, 2020
Self-reported physical activity and atrial fibrillation risk: A systematic review and meta-analysisRicardo S Mishima, Christian V Verdicchio, Jean Jacques Noubiap, et al.
ESMO Open|December 12, 2025
E7386 in patients with advanced solid tumors: results from the dose-escalation part and an expansion part of a phase I studyS Kondo, N Yamamoto, Y Katsuya, et al.
JACC. Clinical Electrophysiology|February 25, 2022
Autonomic Afferent Dysregulation in Atrial FibrillationVarun Malik, Adrian D Elliott, Gijo Thomas, et al.
BMJ Open|August 10, 2021
Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiencySamuel J Tu, Adrian D Elliott, Nicole Hanna-Rivero, et al.
ESMO Gastrointestinal Oncology|May 28, 2026
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trialD Okemoto, D Kotani, M Nakamura, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancerK Yamamoto, I Nakayama, N Sakamoto, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
JACC. Heart Failure|September 7, 2023
Identification of Subclinical Heart Failure With Preserved Ejection Fraction in Patients With Symptomatic Atrial FibrillationJonathan P Ariyaratnam, Adrian D Elliott, Ricardo S Mishima, et al.
JACC. Clinical Electrophysiology|February 8, 2023
An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled TrialAdrian D Elliott, Christian V Verdicchio, Rajiv Mahajan, et al.
Heart, Lung & Circulation|April 24, 2022
Should We Check It? Assessing Interrogation of Cardiac Implantable Electronic Devices in the Emergency Department-The CHECK-ED Study: Implications for Service Planning and Care DeliveryBradley M Pitman, Vincent Schirripa, Dian A Munawar, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Safety and efficacy of perioperative FLOT regimen in Japanese patients with gastric, esophagogastric junction, or esophageal adenocarcinoma: a single-institution experienceS Takei, A Kawazoe, A Jubashi, et al.
Heart Rhythm|December 21, 2020
Self-reported physical activity and atrial fibrillation risk: A systematic review and meta-analysisRicardo S Mishima, Christian V Verdicchio, Jean Jacques Noubiap, et al.
ESMO Open|December 12, 2025
E7386 in patients with advanced solid tumors: results from the dose-escalation part and an expansion part of a phase I studyS Kondo, N Yamamoto, Y Katsuya, et al.
JACC. Clinical Electrophysiology|February 25, 2022
Autonomic Afferent Dysregulation in Atrial FibrillationVarun Malik, Adrian D Elliott, Gijo Thomas, et al.
BMJ Open|August 10, 2021
Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiencySamuel J Tu, Adrian D Elliott, Nicole Hanna-Rivero, et al.
ESMO Gastrointestinal Oncology|May 28, 2026
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trialD Okemoto, D Kotani, M Nakamura, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancerK Yamamoto, I Nakayama, N Sakamoto, et al.
Pageof 13